1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders
    Journal Article

    Pulitzer, M.; Geller, S.; Kumar, E.; Frosina, D.; Moskowitz, A.; Horwitz, S.; Myskowski, P.; Kheterpal, M.; Chan, A.; Dogan, A.; more...
    Histopathology (2018)

    Fulltext@MSK | Save
  • Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study
    Journal Article

    Flinn, I. W.; Patel, M.; Oki, Y.; Horwitz, S.; Foss, F. F.; Allen, K.; Douglas, M.; Stern, H.; Sweeney, J.; Kharidia, J.; more...
    American Journal of Hematology (2018)

    Fulltext@MSK | Save
  • Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): An international, open-label, randomised, controlled phase 3 trial
    Journal Article

    Kim, Y. H.; Bagot, M.; Pinter-Brown, L.; Rook, A. H.; Porcu, P.; Horwitz, S. M.; Whittaker, S.; Tokura, Y.; Vermeer, M.; Zinzani, P. L.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter phase II study of sequential brentuximab vedotin and doxorubicin, vinblastine, and dacarbazine chemotherapy for older patients with untreated classical hodgkin lymphoma
    Journal Article

    Evens, A. M.; Advani, R. H.; Helenowski, I. B.; Fanale, M.; Smith, S. M.; Jovanovic, B. D.; Bociek, G. R.; Klein, A. K.; Winter, J. N.; Gordon, L. I.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia
    Journal Article

    Castillo, J. J.; Gustine, J. N.; Meid, K.; Dubeau, T. E.; Xu, L.; Yang, G.; Hunter, Z. R.; Advani, R.; Palomba, L.; Treon, S. P.
    Haematologica (2018)

    Fulltext@MSK | Save
  • Limited-stage Hodgkin lymphoma: Minimizing toxicity
    Journal Article

    Straus, D. J.
    The Cancer Journal (2018)

    Fulltext@MSK | Save
  • Pembrolizumab in mycosis fungoides and Sezary syndrome: Updated results of the CITN multicenter Phase 2 study
    Meeting Abstract

    Khodadoust, M. S.; Rook, A. H.; Porcu, P.; Foss, F.; Moskowitz, A.; Shustov, A. R.; Shanbhag, S.; Sokol, L.; Fling, S. P.; Li, S.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Ibrutinib/rituximab versus placebo/rituximab: A randomized, phase 3 trial in Waldenström's macroglobulinemia (iNNOVATE)
    Meeting Abstract

    Palomba, M. L.; Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; MacDonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • Treatment of newly-diagnosed classical Hodgkin lymphoma
    Meeting Abstract

    Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • First-generation and second-generation Bruton tyrosine kinase inhibitors in Waldenström macroglobulinemia
    Journal Article

    Argyropoulos, K. V.; Lia, M.
    Hematology/Oncology Clinics of North America (2018)

    Fulltext@MSK | Save